Hvsen Biotechnology Future Growth
Future criteria checks 5/6
Hvsen Biotechnology is forecast to grow earnings and revenue by 80.7% and 22.2% per annum respectively. EPS is expected to grow by 80.6% per annum. Return on equity is forecast to be 8% in 3 years.
Key information
80.7%
Earnings growth rate
80.6%
EPS growth rate
| Pharmaceuticals earnings growth | 19.2% |
| Revenue growth rate | 22.2% |
| Future return on equity | 8.0% |
| Analyst coverage | Low |
| Last updated | 06 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Hvsen Biotechnology Co., Ltd. (SZSE:300871) Shares Could Be 21% Below Their Intrinsic Value Estimate
Aug 21
Take Care Before Jumping Onto Hvsen Biotechnology Co., Ltd. (SZSE:300871) Even Though It's 27% Cheaper
Jun 05Hvsen Biotechnology Co., Ltd. (SZSE:300871) Stocks Shoot Up 37% But Its P/E Still Looks Reasonable
Mar 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,801 | 128 | 227 | 269 | 2 |
| 12/31/2025 | 1,566 | 137 | 116 | 202 | 2 |
| 12/31/2024 | 1,246 | 37 | -79 | 146 | 2 |
| 6/30/2024 | 1,007 | -51 | -139 | 56 | N/A |
| 3/31/2024 | 996 | -14 | -139 | 64 | N/A |
| 12/31/2023 | 1,020 | 17 | -91 | 93 | N/A |
| 9/30/2023 | 1,043 | 41 | -167 | 80 | N/A |
| 6/30/2023 | 1,075 | 62 | -225 | 77 | N/A |
| 3/31/2023 | 1,048 | 66 | -257 | 96 | N/A |
| 1/1/2023 | 1,023 | 53 | -332 | 97 | N/A |
| 9/30/2022 | 922 | 40 | -320 | 109 | N/A |
| 6/30/2022 | 857 | 38 | -471 | 120 | N/A |
| 3/31/2022 | 888 | 71 | -488 | 160 | N/A |
| 1/1/2022 | 996 | 133 | -444 | 156 | N/A |
| 9/30/2021 | 1,027 | 173 | -447 | 125 | N/A |
| 6/30/2021 | 1,026 | 199 | -319 | 88 | N/A |
| 3/31/2021 | 956 | 188 | -277 | 17 | N/A |
| 12/31/2020 | 777 | 150 | -182 | 48 | N/A |
| 9/30/2020 | 655 | 130 | -97 | 111 | N/A |
| 12/31/2019 | 427 | 69 | -18 | 105 | N/A |
| 12/31/2018 | 422 | 71 | -13 | 21 | N/A |
| 12/31/2017 | 400 | 88 | N/A | 81 | N/A |
| 12/31/2016 | 258 | 49 | N/A | 60 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300871 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 300871 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300871 is expected to become profitable in the next 3 years.
Revenue vs Market: 300871's revenue (22.2% per year) is forecast to grow faster than the CN market (13.2% per year).
High Growth Revenue: 300871's revenue (22.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300871's Return on Equity is forecast to be low in 3 years time (8%).